<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Vigna, C.</title>
    <link>http://repub.eur.nl/res/aut/2163/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12934/</link>
      <pubDate>2001-08-22T00:00:00Z</pubDate>
      <description>AIM: To assess the long-term cardioprotective effect of bisoprolol in a
          randomized high-risk population after successful major vascular surgery.
          High-risk patients were defined by the presence of one or more cardiac
          risk factor(s) and a dobutamine echocardiography test positive for
          ischaemia. METHODS: 1351 patients were screened prior to surgery, 846
          patients had one or more risk factor(s), and 173 of these patients also
          had ischaemia during dobutamine echocardiography. One hundred and twelve
          patients could be randomized for additional bisoprolol therapy or standard
          care. Eleven patients died in the peri-operative period (up to 1 month
          after surgery). Randomized patients continued bisoprolol or standard care
          after surgery. During follow-up of 101 survivors (median 22 months, range
          11-30) cardiac death or myocardial infarction was noted. No patient was
          lost during follow-up.Results The incidence of cardiac events during
          follow-up in the bisoprolol group was 12% vs 32% in the standard care
          group (P=0.025). Cardiac death occurred in 15 patients, nine patients in
          the standard care and in six in the bisoprolol group; myocardial
          infarction occurred in six patients, five in the standard care and one in
          the bisoprolol group. The odds ratio for cardiac death or myocardial
          infarction after surgery in high-risk patients with additional bisoprolol
          therapy was 0.30 (0.11-0.83). CONCLUSIONS: Bisoprolol significantly
          reduced long-term cardiac death and myocardial infarction in high-risk
          patients after successful major cardiac vascular surgery.</description>
    </item> <item>
      <title>Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12886/</link>
      <pubDate>2000-10-30T00:00:00Z</pubDate>
      <description>BACKGROUND: Patients with left bundle branch block exhibit abnormal septal
      motion which may limit the interpretation of stress echocardiograms. This
      study sought to assess the diagnostic value of dobutamine-atropine stress
      echocardiography in left bundle branch block patients. METHODS AND
      RESULTS: Sixty-four left bundle branch block patients (mean age 59 years,
      24 men) with suspected coronary artery disease underwent
      dobutamine-atropine stress echocardiography and coronary arteriography.
      Myocardial ischaemia was defined as new or worsening wall thickening
      abnormalities. Coronary artery disease was quantitatively defined as a
      diameter stenosis &gt;/=50% in a major epicardial artery. Rest septal motion
      was normal (apart from the early systolic septal notch) in 34 patients
      (53%) and abnormal in 30 patients (47%). Rest septal thickening was normal
      in 32 patients (50%) and abnormal in 32 patients (50%). All seven patients
      with a QRS duration &gt;/=160 ms and an abnormal QRS axis had abnormal rest
      septal motion and thickening. Inter-observer agreement for ischaemia was
      88%. In all but one patient disagreement was in the septum. For the
      anterior and posterior circulation, respectively, sensitivity was 60%
      (9/15) and 67% (8/12), specificity was 94% (46/49) and 98% (51/52), and
      accuracy was 86% (55/64) and 92% (59/64). Sensitivity for the anterior
      circulation tended to be better in patients with normal rest septal
      thickening (83% vs 44%). CONCLUSIONS: Dobutamine-atropine stress
      echocardiography has excellent diagnostic specificity in left bundle
      branch block patients with suspected coronary artery disease. In patients
      with abnormal rest septal thickening, however, dobutamine-atropine stress
      echocardiography may lack good sensitivity for detection of coronary
      artery disease in the anterior circulation. Left bundle branch block
      patients who potentially most benefit from dobutamine-atropine stress
      echocardiography may initially be selected by their resting
      electrocardiogram.</description>
    </item> <item>
      <title>The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group (Article)</title>
      <link>http://repub.eur.nl/res/pub/9207/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Cardiovascular complications are the most important causes of
          perioperative morbidity and mortality among patients undergoing major
          vascular surgery. METHODS: We performed a randomized, multicenter trial to
          assess the effect of perioperative blockade of beta-adrenergic receptors
          on the incidence of death from cardiac causes and nonfatal myocardial
          infarction within 30 days after major vascular surgery in patients at high
          risk for these events. High-risk patients were identified by the presence
          of both clinical risk factors and positive results on dobutamine
          echocardiography. Eligible patients were randomly assigned to receive
          standard perioperative care or standard care plus perioperative
          beta-blockade with bisoprolol. RESULTS: A total of 1351 patients were
          screened, and 846 were found to have one or more cardiac risk factors. Of
          these 846 patients, 173 had positive results on dobutamine
          echocardiography. Fifty-nine patients were randomly assigned to receive
          bisoprolol, and 53 to receive standard care. Fifty-three patients were
          excluded from randomization because they were already taking a
          beta-blocker, and eight were excluded because they had extensive
          wall-motion abnormalities either at rest or during stress testing. Two
          patients in the bisoprolol group died of cardiac causes (3.4 percent), as
          compared with nine patients in the standard-care group (17 percent,
          P=0.02). Nonfatal myocardial infarction occurred in nine patients given
          standard care only (17 percent) and in none of those given standard care
          plus bisoprolol (P&lt;0.001). Thus, the primary study end point of death from
          cardiac causes or nonfatal myocardial infarction occurred in 2 patients in
          the bisoprolol group (3.4 percent) and 18 patients in the standard-care
          group (34 percent, P&lt;0.001). CONCLUSIONS: Bisoprolol reduces the
          perioperative incidence of death from cardiac causes and nonfatal
          myocardial infarction in high-risk patients who are undergoing major
          vascular surgery.</description>
    </item>
  </channel>
</rss>